FDA Issues Class I Recall for Edwards Lifesciences Heart Device After Fatality

Key Facts

1The FDA classified the recall of Edwards Lifesciences' Commander M delivery systems as Class I, the most serious type.

2The recall followed reports of balloon bursts during use, which resulted in at least one patient death.

The FDA classified the recall of Edwards Lifesciences' Commander M delivery systems as Class I, the most serious type of regulatory alert. Benzinga reported that the recall followed reports of balloon bursts during medical procedures, which resulted in at least one patient death.

Edwards Lifesciences stock, trading under the ticker EW, closed at $88.1 on October 15, 2026. The instrument saw a session range between a low of $85.54 and a high of $88.41 on that date as markets processed the impact of the safety failure on the company's cardiovascular portfolio.